Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan

2003 ◽  
Vol 15 (1) ◽  
pp. 27-33 ◽  
Author(s):  
Ikuya Miki ◽  
Nobuo Aoyama ◽  
Toshiyuki Sakai ◽  
Daisuke Shirasaka ◽  
Casmir Marwa Wambura ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Genetic Polymorphism ◽  
Triple Therapy ◽  
Treatment Efficacy ◽  
Helicobacter Pylori Infection ◽  
Clarithromycin Resistance

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism

2001 ◽  
Vol 15 (9) ◽  
pp. 1479-1484 ◽  
Author(s):  
K. Hokari ◽  
T. Sugiyama ◽  
M. Kato ◽  
M. Saito ◽  
T. Miyagishima ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Genetic Polymorphism ◽  
Triple Therapy ◽  
Helicobacter Pylori Infection

scholarly journals Clarithromycin-Based Triple Therapy Is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic

2017 ◽  
pp. 16-0729 ◽  
Author(s):  
Muhammad Miftahussurur ◽  
Modesto Cruz ◽  
Phawinee Subsomwong ◽  
José A. Jiménez Abreu ◽  
Celso Hosking ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Dominican Republic ◽  
Triple Therapy ◽  
Initial Treatment ◽  
Helicobacter Pylori Infection
Sign in / Sign up

Export Citation Format

Share Document